These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 25123332

  • 1. Serum soluble CD40 Ligand levels are associated with severity and mortality of brain trauma injury patients.
    Lorente L, Martín MM, González-Rivero AF, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Serrano N, Rodríguez ST, Jiménez A, Borreguero-León JM.
    Thromb Res; 2014 Oct; 134(4):832-6. PubMed ID: 25123332
    [Abstract] [Full Text] [Related]

  • 2. Total antioxidant capacity is associated with mortality of patients with severe traumatic brain injury.
    Lorente L, Martín MM, Almeida T, Abreu-González P, Ramos L, Argueso M, Riaño-Ruiz M, Solé-Violán J, Jiménez A.
    BMC Neurol; 2015 Jul 25; 15():115. PubMed ID: 26205136
    [Abstract] [Full Text] [Related]

  • 3. Nonsurviving Patients with Severe Traumatic Brain Injury Have Maintained High Serum sCD40L Levels.
    Lorente L, Martín MM, González-Rivero AF, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A, Borreguero-León JM, García-Marín V.
    World Neurosurg; 2019 Jun 25; 126():e1537-e1541. PubMed ID: 30926559
    [Abstract] [Full Text] [Related]

  • 4. Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury.
    Lorente L, Martín MM, López P, Ramos L, Blanquer J, Cáceres JJ, Solé-Violán J, Solera J, Cabrera J, Argueso M, Ortiz R, Mora ML, Lubillo S, Jiménez A, Borreguero-León JM, González A, Orbe J, Rodríguez JA, Páramo JA.
    PLoS One; 2014 Jun 25; 9(4):e94370. PubMed ID: 24728097
    [Abstract] [Full Text] [Related]

  • 5. Serum caspase-3 levels and mortality are associated in patients with severe traumatic brain injury.
    Lorente L, Martín MM, Argueso M, Ramos L, Solé-Violán J, Riaño-Ruiz M, Jiménez A, Borreguero-León JM.
    BMC Neurol; 2015 Nov 06; 15():228. PubMed ID: 26545730
    [Abstract] [Full Text] [Related]

  • 6. Serum substance P levels are associated with severity and mortality in patients with severe traumatic brain injury.
    Lorente L, Martín MM, Almeida T, Hernández M, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A.
    Crit Care; 2015 Apr 27; 19(1):192. PubMed ID: 25928056
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High Serum Soluble Fas Ligand Levels in Non-survivor Traumatic Brain Injury Patients.
    Lorente L, Martín MM, Pérez-Cejas A, González-Rivero AF, Ramos-Gómez L, Solé-Violán J, Cáceres JJ, Cabrera J, Alvarez-Castillo A, Ferrer-Moure C, Jiménez A.
    Neurocrit Care; 2021 Aug 27; 35(1):249-254. PubMed ID: 33403586
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Significance of troponin elevation after severe traumatic brain injury.
    Salim A, Hadjizacharia P, Brown C, Inaba K, Teixeira PG, Chan L, Rhee P, Demetriades D.
    J Trauma; 2008 Jan 27; 64(1):46-52. PubMed ID: 18188098
    [Abstract] [Full Text] [Related]

  • 11. Association between serum malondialdehyde levels and mortality in patients with severe brain trauma injury.
    Lorente L, Martín MM, Abreu-González P, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Lorenzo JM, Molina I, Jiménez A.
    J Neurotrauma; 2015 Jan 01; 32(1):1-6. PubMed ID: 25054973
    [Abstract] [Full Text] [Related]

  • 12. Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury.
    Gatson JW, Barillas J, Hynan LS, Diaz-Arrastia R, Wolf SE, Minei JP.
    J Neurosurg; 2014 Nov 01; 121(5):1232-8. PubMed ID: 25192482
    [Abstract] [Full Text] [Related]

  • 13. The prognostic value of plasma soluble CD40 ligand levels following aneurysmal subarachnoid hemorrhage.
    Chen XD, Sun J, Lu C, Ba HJ, Chen MH, Lin JH, Cai JY.
    Thromb Res; 2015 Jul 01; 136(1):24-9. PubMed ID: 25944664
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Copeptin is associated with mortality in patients with traumatic brain injury.
    Dong XQ, Huang M, Yang SB, Yu WH, Zhang ZY.
    J Trauma; 2011 Nov 01; 71(5):1194-8. PubMed ID: 21502880
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Posttraumatic cerebral infarction: incidence, outcome, and risk factors.
    Tawil I, Stein DM, Mirvis SE, Scalea TM.
    J Trauma; 2008 Apr 01; 64(4):849-53. PubMed ID: 18404047
    [Abstract] [Full Text] [Related]

  • 18. Glial fibrillary acidic protein is highly correlated with brain injury.
    Lumpkins KM, Bochicchio GV, Keledjian K, Simard JM, McCunn M, Scalea T.
    J Trauma; 2008 Oct 01; 65(4):778-82; discussion 782-4. PubMed ID: 18849790
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum ethanol levels: predictor of survival after severe traumatic brain injury.
    Salim A, Teixeira P, Ley EJ, DuBose J, Inaba K, Margulies DR.
    J Trauma; 2009 Oct 01; 67(4):697-703. PubMed ID: 19820573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.